Navigation Links
LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology

PHILADELPHIA, Feb. 20, 2013 /PRNewswire/ -- LaserLock Technologies, Inc. (OTCBB: LLTI), a global leader in providing state-of-the-art authentication solutions to governments, pharmaceuticals, high-end retailers, and casinos announced it has filed a provisional patent application for a Characteristic Verification System (CVS) enabling smart phones to simultaneously identify counterfeit products and protect against identity fraud. The CVS is a groundbreaking technology that sets a new standard in brand protection by combining LaserLock's proven product authentication expertise with its recently acquired VerifyMe™ human authentication technology.  

Acquired by LaserLock Technologies in December 2012, VerifyMe™ is a biometric verification system that uses a smartphone platform and a variety of methods to quickly and accurately prove the identity of any human being. It can also uniquely serialize individual products allowing complete verification of provenance, pedigree and movement.  The new solution benefits from the near ubiquitous penetration of smart phones with integrated cameras and artificial light sources to create advanced inspection tools that can be made available at no additional cost.

"LaserLock's new CVS provisional patent application is uniquely well-suited to take advantage of the increasing demand for more effective, more economical and more efficient authentication technology along supply chains," said Neil Alpert , President of LaserLock Technologies. "This provisional patent application is a potential game-changer for our company and our industry."

The Characteristic Verification System utilizes technologies present in virtually all smartphones to capture both overt and covert anti-counterfeiting measures on any given product, as well as verify the identity of the person performing that action. Its applications range from protecting the most complex and sensitive supply chains to protecting the integrity of high-value retail goods.

"As more industries demand both human and product authentication simultaneously, LaserLock is positioned to assume a leadership role in this arena," said Michael Sonnenreich , Chairman of LaserLock Technologies' Board of Directors. "Just last week, the Institute of Medicine recommended that the United States Congress authorize and fund a mandatory track-and-trace program in the pharmaceutical industry that our technology is already designed to achieve."

Additionally, LaserLock will be releasing VerifyMe™ applications for Android, BlackBerry, iOS and Windows mobile devices including phones and tablets.


LaserLock Technologies, Inc. based in Bala Cynwyd, PA is publicly traded on the OTC Market under the ticker symbol "LLTI". The Company markets security technology to protect pharmaceuticals, high-end retail goods, the casino industry, documents and branded products from counterfeiting. To learn more, visit us at or follow us on Twitter @LaserLockTech.

Sarah Jane Scruggs
Sage Communications (for LaserLock Technologies)

LaserLock Technologies


SOURCE LaserLock Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
2. New modeling approach transforms imaging technologies
3. Life Technologies ayudar√° a identificar 20.000 restos humanos encontrados en fosas comunes en Libia
4. New supercomputer coming to EMSL this summer, supplied by Atipa Technologies
5. UT Dallas researchers awarded $4.3 million to create next-generation technologies
6. ASU partners with Life Technologies on US DHHS funded project to rapidly assess radiation dose
7. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
8. NREL researchers use imaging technologies to solve puzzle of plant architecture
9. New energy technologies promise brighter future
10. Cross Match Technologies Undoubtedly Offers the Highest Value to Customers in the North American Biometrics Market, Says Frost & Sullivan
11. Life Technologies to supply new Covaris DNA fragmenting products for Ion Torrent Semiconductor Sequencers
Post Your Comments:
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology: